Avi is a Senior Health Policy Associate with LSE Health and a PhD candidate in the Department of Health Policy at the London School of Economics. While working at LSE Health, he has consulted for Ministries of Health and international organisations on several topics including high-cost medicines, low-value care, and health system reform.
Avi’s published research has focused on the evidence and effectiveness of new drugs in the United States and Europe. His PhD investigates the use of expedited regulations for new cancer drugs in the US and the implications this has for evidence development and insurance coverage. Prior to joining the department, Avi earned an MSc from the London School of Economics and the London School of Hygiene and Tropical Medicine.